The Business of Health & Life Science

The Business of Health Care & Life Science

The Business of Health & Life Science

The Business of Health Care and Life Science™ is unique from any other industry for the reasons of systemic product life-cycle uncertainties, investigational risk and novelty:

Product Life-Cycle Uncertainties
"Product Life-Cycle Uncertainties" are derived from the high variance inherent to the creation of novel investigational products.  These uncertainties take the form of operating and capital costs, product life-cycle times and sales. These unknowns can have a direct and profound impact on an organization’s ability to rapidly generate as well as destroy health care and scientific value.

Investigational Product Risk
"Investigational Product Risk" is an equally important factor and is systemic to the "science" of the investigational product and the "environment" for which it exists.  These risks can take the form of product efficacy and safety, regulatory approval, payor reimbursement, order of market entry, and others.  Risk can never be eliminated, however one can prospectively manage and make business decisions that will evolve and optimize business value by anticipating and incorporating the risks inherent to these business decisions.

Limited Product Novelty
"Limited Product Novelty," due to patent expiration or hyper-competition, creates a finite period in which optimal value for the product may be realized.  Once the "clock" begins, one’s time to realize value is limited by the opportunity cost of losing the novel and unique position in the market.

The Value Framework™ incorporates these product life-cycle uncertainties, investigational risk and novelty, allowing our advisors to predictably and sustainably improve the Business of Health Care and Life Science™.